These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7696015)

  • 1. Is thrombolytic therapy in acute inferior myocardial infarction really better than conventional treatment?
    Tobé TJ
    Br Heart J; 1995 Feb; 73(2):108-9. PubMed ID: 7696015
    [No Abstract]   [Full Text] [Related]  

  • 2. ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
    Collins R; Peto R; Parish S; Sleight P
    Am J Cardiol; 1993 May; 71(12):1127-30. PubMed ID: 8475887
    [No Abstract]   [Full Text] [Related]  

  • 3. Stroke associated with thrombolytic therapy for acute myocardial infarction.
    Sloan MA
    Heart Dis Stroke; 1992; 1(5):287-94. PubMed ID: 1344119
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strokes and net clinical benefit.
    White H
    Aust N Z J Med; 1993 Dec; 23(6):737-8. PubMed ID: 8141714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptokinase in acute myocardial infarction.
    Rajagopalan RS
    J Assoc Physicians India; 1993 Jun; 41(6):325-6. PubMed ID: 8005961
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
    Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke in patients treated with thrombolytic therapy for acute myocardial infarction. The thrombosis in myocardial infarction clinical trial and a review of placebo-controlled trials.
    Price TR
    Stroke; 1990 Nov; 21(11 Suppl):III8-9. PubMed ID: 2122557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy for elderly patients.
    Topol EJ; Califf RM
    N Engl J Med; 1992 Jul; 327(1):45-7. PubMed ID: 1598101
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary arterial aneurysm after percutaneous transluminal coronary recanalization with streptokinase.
    Chen MF; Liau CS; Lee YT
    Int J Cardiol; 1990 Jul; 28(1):117-9. PubMed ID: 2365525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptokinase-induced jaundice in patients with acute myocardial infarction.
    Mager A; Birnbaum Y; Zlotikamien B; Strasberg B; Rechavia E; Sagie A; Sclarovsky S
    Am Heart J; 1991 May; 121(5):1543-4. PubMed ID: 2017987
    [No Abstract]   [Full Text] [Related]  

  • 17. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction.
    Queen M; Biem HJ; Moe GW; Sugar L
    Am J Cardiol; 1990 Apr; 65(15):1042-3. PubMed ID: 2327344
    [No Abstract]   [Full Text] [Related]  

  • 19. The need to identify patients who have received streptokinase therapy.
    Salem DN; Pauker SG
    N Engl J Med; 1991 Jun; 324(24):1742. PubMed ID: 2034254
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy for coronary occlusion.
    Thompson PL
    Med J Aust; 1992 Jul; 157(2):75-7. PubMed ID: 1630392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.